Cargando…
Can Regulatory Efforts Motivate Innovation? The Case of Ventilator Innovations During COVID
In 2020, the United States Food and Drug Administration enacted the Emergency Use Authorization (EUA) to help respond to the COVID-19 pandemic. This regulatory pathway allowed for alternative uses of the existing medical devices and temporary authorization of new medical device designs, including ve...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
IEEE
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956369/ http://dx.doi.org/10.1109/EMR.2021.3127452 |